Literature DB >> 10862642

Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids.

A A House1, G A Wells, J G Donnelly, S P Nadler, P C Hébert.   

Abstract

BACKGROUND: Uncontrolled studies have found that high-flux haemodialysis favourably modifies homocysteine and lipid profiles. We sought to confirm these findings by carrying out a randomized prospective comparison of high-flux and low-flux polysulphone in chronic, stable dialysis patients.
METHODS: Forty-eight patients were randomly assigned to either high or low-flux dialysis for 3 months. Serum levels of homocysteine, lipoprotein (a), and lipids were compared between the treatment groups at monthly intervals.
RESULTS: All patient characteristics and laboratory variables were equally distributed between the groups at baseline. Over the study duration, we observed no differences between high- and low-flux treatment groups for the following outcomes: pre-dialysis homocysteine, lipoprotein (a), total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides (all P>0.05). Geometric mean (interquartile range) homocysteine at baseline was 20.0 (16.8-24.5) and 19.5 (15.3-22.0) micromol/l for the high-and low-flux groups respectively (P=0.80), and levels did not change significantly during the study. We did demonstrate a more pronounced intradialytic effect of high-flux dialysis on homocysteine levels, which fell during dialysis by 42%, compared to 32% with low-flux dialysis (P<0. 001).
CONCLUSIONS: In this randomized controlled trial, the effects of high-flux and low-flux haemodialysis on homocysteine and lipid profiles were comparable. The greater intradialytic effect of high-flux dialysis on homocysteine did not translate into a significant difference in pre-dialysis levels after 3 months of study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862642     DOI: 10.1093/ndt/15.7.1029

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Cardiorenal syndrome type 4: a review.

Authors:  Anna Clementi; Grazia Maria Virzì; Ching Yan Goh; Dinna N Cruz; Antonio Granata; Girogio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

2.  Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes.

Authors:  Mariarita Dessì; Gianna Di Giovamberardino; Massimo Pieri; Annalisa Noce; Rossella Zenobi; Nicola Di Daniele; Anna Pastore
Journal:  Clin Exp Nephrol       Date:  2014-03-21       Impact factor: 2.801

Review 3.  Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.

Authors:  Roberto Scarpioni; Marco Ricardi; Vittorio Albertazzi; Luigi Melfa
Journal:  World J Nephrol       Date:  2012-12-06

Review 4.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

5.  Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.

Authors:  Philip Kam-Tao Li; Yuk Lun Cheng; Chi Bon Leung; Cheuk Chun Szeto; Kai Ming Chow; Bonnie Ching-Ha Kwan; Esther Siu-Chun Ng; Queenie Wing-Yi Fok; Yuet Ling Poon; Alex Wai-Yin Yu
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

6.  Homocysteine and C-reactive protein levels in haemodialysis patients.

Authors:  E Koulouridis; M Tzilianos; A Katsarou; I Costimba; E Klonou; E Panagiotaki; C Georgalidis; A Krokida; N Delaportas; A Lachanas; G Karaliotas; I Kaliolia
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

7.  Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

Authors:  Bradley L Urquhart; David J Freeman; Murray J Cutler; Rahul Mainra; J David Spence; Andrew A House
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 8.237

8.  High-flux and low-flux membranes: efficacy in hemodialysis.

Authors:  Khodayar Oshvandi; Rasol Kavyannejad; Sayed Reza Borzuo; Mahmoud Gholyaf
Journal:  Nurs Midwifery Stud       Date:  2014-09-20

9.  Modulation of blood pressure regulatory genes in the Agtrap-Plod1 locus associated with a deletion in Clcn6.

Authors:  Christine A Klemens; Lashodya V Dissanayake; Vladislav Levchenko; Adrian Zietara; Oleg Palygin; Alexander Staruschenko
Journal:  Physiol Rep       Date:  2022-08

Review 10.  Update on the Classification and Pathophysiological Mechanisms of Pediatric Cardiorenal Syndromes.

Authors:  Giorgia Ceravolo; Tommaso La Macchia; Caterina Cuppari; Valeria Dipasquale; Antonella Gambadauro; Celeste Casto; Maria Domenica Ceravolo; Maricia Cutrupi; Maria Pia Calabrò; Paola Borgia; Gianluca Piccolo; Alessio Mancuso; Remo Albiero; Roberto Chimenz
Journal:  Children (Basel)       Date:  2021-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.